“BATF/RORgt/IL-17 Axis as a Therapeutic Target in Systemic Lupus Erythematosus: Integrative Bioinformatics and In Vivo Validation of Langchuangding Combined with Prednisone”, ACTA, vol. 89, Jun. 2026, doi: 10.52152/FH9183.